Skip to content
Disclosery

MRA Advisory Group: MOD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on MOD, newest first. How the timeline and the estimate are built.

MRA Advisory Group held 5,304 MOD shares at 2026-09-30 per its 13F-HR filed 2026-10-07.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 5,304 shares
    Change vs previous 13F +982 shares

    0.37% of the 13F portfolio, value $992,952.

    13F-HR 0001841816-26-000007 filed by MRA Advisory Group
    Accepted , ingested

  2. period ended2026-06-30
    13F 4,322 shares
    Change vs previous 13F -1,239 shares

    0.42% of the 13F portfolio, value $1,153,949.

    13F-HR 0001841816-26-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 5,561 shares
    Change vs previous 13F -190 shares

    0.49% of the 13F portfolio, value $1,205,229.

    13F-HR 0001841816-26-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 5,751 shares
    Change vs previous 13F +250 shares

    0.32% of the 13F portfolio, value $767,772.

    13F-HR 0001841816-26-000001 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 5,501 shares
    Change vs previous 13F -265 shares

    0.34% of the 13F portfolio, value $781,957.

    13F-HR 0001841816-25-000005 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 5,766 shares
    Change vs previous 13F not available

    0.27% of the 13F portfolio, value $567,950.

    13F-HR 0001841816-25-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).